The availability of gonadotropin therapy from FDA-approved pharmacies for men with hypogonadism and infertility

BACKGROUND: Recent changes to the Biologics Price Competition and Innovation Act of 2009 have created barriers to accessing therapy for men utilizing gonadotropins for hypogonadism and infertility. AIM: In this study we sought to investigate ways to decrease disparities in the treatment of male hypo...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgert, Benjamin J, Bacchus, Michael W, Hernandez, Alexandra D, Potts, Shelby N, Campbell, Kevin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pharmacotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083688/
https://www.ncbi.nlm.nih.gov/pubmed/37051549
http://dx.doi.org/10.1093/sexmed/qfad004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083688/
https://www.ncbi.nlm.nih.gov/pubmed/37051549
http://dx.doi.org/10.1093/sexmed/qfad004

Ejemplares similares